SKI Market

A+| A| A-|

Indian Indices

Sensex

74,608.98 49.74
( 0.07%)

Global Indices

Nasdaq

49,785.17 59.69
(0.12%)

Dow Jones

7,421.51 -12.33
(-0.17%)

Hang Seng

63,198.64 456.07
(0.73%)

Nikkei 225

10,253.59 -15.84
(-0.15%)

Forex

USD-INR

95.14 0.72
(0.77%)

EUR-INR

111.99 0.76
(0.69%)

GBP-INR

129.47 0.85
(0.66%)

JPY-INR

0.61 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

101.48

442893.24

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.87

Back

V2 Retail reports consolidated net profit of Rs 17.23 crore in the September 2025 quarter

Nov 16,2025

Net profit of V2 Retail reported to Rs 17.23 crore in the quarter ended September 2025 as against net loss of Rs 1.93 crore during the previous quarter ended September 2024. Sales rose 86.48% to Rs 708.64 crore in the quarter ended September 2025 as against Rs 380.01 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	708.64	380.01	86
OPM %	12.06	8.70	-
PBDT	58.53	20.60	184
PBT	20.95	-2.43	LP
NP	17.23	-1.93	LP

74,608.98 49.74 ( 0.07%)

49,785.17 59.69 (0.12%)

7,421.51 -12.33 (-0.17%)

63,198.64 456.07 (0.73%)

10,253.59 -15.84 (-0.15%)

95.14 0.72 (0.77%)

111.99 0.76 (0.69%)

129.47 0.85 (0.66%)

0.61 0.00 (0.51%)